dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Trippett, Tanya |
dc.contributor.author | Toledano, Helen |
dc.contributor.author | Campbell Hewson, Quentin |
dc.contributor.author | Verschuur, Arnauld |
dc.contributor.author | Langevin, Anne‑Marie |
dc.contributor.author | Gallego Melcón, Soledad |
dc.contributor.author | Aerts, Isabelle |
dc.date.accessioned | 2022-09-12T09:23:00Z |
dc.date.available | 2022-09-12T09:23:00Z |
dc.date.issued | 2022-05 |
dc.identifier.citation | Trippett T, Toledano H, Campbell Hewson Q, Verschuur A, Langevin AM, Aerts I, et al. Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study. Target Oncol. 2022 May;17(3):283–93. |
dc.identifier.issn | 1776-260X |
dc.identifier.uri | https://hdl.handle.net/11351/8147 |
dc.description | Cobimetinib; Pediatria; Tumors sòlids refractaris |
dc.language.iso | eng |
dc.publisher | Springer |
dc.relation.ispartofseries | Targeted Oncology;17(3) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Farmacocinètica |
dc.subject | Posologia |
dc.subject | Càncer - Tractament |
dc.subject.mesh | Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Pharmacokinetics |
dc.subject.mesh | Maximum Tolerated Dose |
dc.title | Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1007/s11523-022-00888-9 |
dc.subject.decs | neoplasias |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | farmacocinética |
dc.subject.decs | dosis máxima tolerada |
dc.relation.publishversion | https://doi.org/10.1007/s11523-022-00888-9 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Trippett T] Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, USA. [Toledano H] Department of Pediatric Hematology-Oncology, Schneider Children's Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. [Campbell Hewson Q] Department of Paediatric and Adolescent Oncology, The Great North Children’s Hospital, Newcastle Upon Tyne, UK. [Verschuur A] Assistance Publique-Hopitaux de Marseille, Pediatric Oncology, Timone Children’s Hospital, Marseille, France. [Langevin AM] Department of Pediatrics, UT Health San Antonio, San Antonio, TX, USA. [Aerts I] Oncology Center SIREDO, Institut Curie, PSL Research University, Paris, France. [Gallego S] Servei d’Oncologia i Hematologia Pediàtriques, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 35715627 |
dc.identifier.wos | 000812474500002 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |